ArticleInflammopharmacology2026

Canagliflozin attenuates Parkinson's disease and is associated with modulation of gut-inflammasome-brain axis in rats.

Nada K Gamal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.